India  /  Published 15.06.22

Covaxin: Defence against Omicron

The administration of Covaxin as a booster dose enhances vaccine effectiveness against Covid-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and B...
By Our Bureau, PTI in New Delhi

News  /  Published 08.06.22

Low turnout for Covid booster dose, doctors warn against missing shot

Covid vaccination centres in the city are witnessing a low turnout for booster doses, officials running the centres have said. The scene has been the same at the centres run by the Kolkata Municipal ...
By Subhajoy Roy in Kolkata

India  /  Published 05.06.22

Corbevax gets nod as booster

A US-designed and India-made Covid-19 vaccine named Corbevax has become the country’s first “heterologous” booster for those who have received two doses of Covishield or Covaxin, the...
By G.S. Mudur in New Delhi

India  /  Published 26.05.22

Germany approves Covaxin

German Ambassador to India and Bhutan, Walter J Lindner on Thursday said the government of the European nation will start recognizing Bharat Biotech's COVID-19 vaccine for travel purpose there fro...
By Our Bureau, PTI in Hyderabad

India  /  Published 24.05.22

FDA lifts hold on Covaxin in US

The US Food and Drug Administration which has put on hold the phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted the pause, according to a statement issued...
By Our Bureau, PTI in Hyderabad


Opinion  /  Published 24.05.22

Forced shot in the arm

In 2021, companies and governments announced new vaccine policies, requiring people to get vaccinated against Covid-19 in order to attend office, dine out, shop at malls or attend gatherings. In the l...
By Sanskruti Yagnik

News  /  Published 20.05.22

RN Tagore hospital offers jabs to 3 Kolkata schools

A private city hospital has approached several schools to administer Covid vaccination to students and teachers free of cost before they run out of stock or the vaccines expire. Some of the schools s...
By Jhinuk Mazumdar in Kolkata

India  /  Published 04.05.22

Bharat Biotech seeks DCGI nod

Bharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two to 18 years, sources told PTI. Pr...
By Our Bureau, PTI in New Delhi

News  /  Published 03.05.22

Uptick in Covid vaccine demand

More people are queuing up for Covid vaccination than a fortnight before. However, the number is still nowhere near what it used to be when the first dose was being administered in 2021, said official...
By Sanjay Mandal in Kolkata

India  /  Published 27.04.22

Two vaccines for under-12 kids

India’s drug regulatory authority has approved two Covid-19 vaccines — Covaxin and Corbevax — for vaccinating children aged between 5 and 12 years, Union health minister Mansukh Mand...
By G.S. Mudur in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.